At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 44 enrolled
Drug / intervention
Moxifloxacin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Influence of the Administration of DAV132 7.5g Tid for 7 Days on the Fecal Levels of Moxifloxacin During and After a 5-day Oral Treatment With Moxifloxacin 400mg Oad in Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating DAV132, Moxifloxacin, and 1 other intervention for Healthy. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether DAV132 is safe and effective for capturing fecal residues of moxifloxacin in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesFrance
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
First PostedJun 2014
Primary CompletionOct 2014
Study CompletionDec 2014
TodayJul 2026
First PostedJun 26, 2014
Enrollment StartMar 1, 2014
Primary CompletionOct 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.0 years ago
Interventions
DAV132device
DAV132 is associated to moxifloxacin or it is evaluated alone
Moxifloxacindrug
Moxifloxacin is used alone or associated to DAV132
Negative Controlother
Moxifloxacin is used alone